FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Münzel

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Disorders

Liver Neoplasms, Experimental

Phenomena

Methylation

Co-author Network

Publications

TOP 3
Michael Schwarz; Peter A Münzel; Albert Braeuning
Non-melanoma skin cancer in mouse and man.
Thomas D Schreiber; Christoph Köhle; Felicitas Buckler; Stephan Schmohl; Albert Braeuning; Alexander Schmiechen; Michael Schwarz; Peter A Münzel
Regulation of CYP1A1 gene expression by the antioxidant tert-butylhydroquinone.
Peter A Münzel; Stephan Schmohl; Felicitas Buckler; Jan Jaehrling; Frank T Raschko; Christoph Köhle; Karl Walter Bock
Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Münzel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michael Schwarz; Peter A Münzel; Albert Braeuning
Non-melanoma skin cancer in mouse and man.
Archives of toxicology 2013;87(5):783-98.
2006: Thomas D Schreiber; Christoph Köhle; Felicitas Buckler; Stephan Schmohl; Albert Braeuning; Alexander Schmiechen; Michael Schwarz; Peter A Münzel
Regulation of CYP1A1 gene expression by the antioxidant tert-butylhydroquinone.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(7):1096-101.
2003: Peter A Münzel; Stephan Schmohl; Felicitas Buckler; Jan Jaehrling; Frank T Raschko; Christoph Köhle; Karl Walter Bock
Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells.
Biochemical pharmacology 2003;66(5):841-7.
2003: Christoph Köhle; Bernd Möhrle; Peter A Münzel; Matthias Schwab; Dorothee Wernet; Osama A Badary; Karl Walter Bock
Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.
Biochemical pharmacology 2003;65(9):1521-7.
2002: Karl Walter Bock; Barbara S Bock-Hennig; Peter A Münzel; Jens Brandenburg; Christoph Köhle; Matthew G Soars; Robert J Riley; Brian Burchell; Oliver Von Richter; Michel Eichelbaum; Stellan Swedmark; Achim Orzechowski
Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by beta-naphthoflavone in comparison with humans.
Biochemical pharmacology 2002;63(9):1683-90.
2000: A Brands; Peter A Münzel; Karl Walter Bock
In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain.
Biochemical pharmacology 2000;59(11):1441-4.
1999: Karl Walter Bock; H Gschaidmeier; H Heel; T Lehmköster; Peter A Münzel; Barbara S Bock-Hennig
Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases.
Drug metabolism reviews 1999;31(2):411-22.
1999: Peter A Münzel; Stephan Schmohl; H Heel; K Kälberer; Barbara S Bock-Hennig; Karl Walter Bock
Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(5):569-73.
1998: Peter A Münzel; T Lehmköster; M Brück; Joseph K Ritter; Karl Walter Bock
Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6.
Archives of biochemistry and biophysics 1998;350(1):72-8.
1998: Karl Walter Bock; H Gschaidmeier; H Heel; T Lehmköster; Peter A Münzel; Frank T Raschko; Barbara S Bock-Hennig
AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms.
Advances in enzyme regulation 1998;38():207-22.
1997: D Ullrich; Peter A Münzel; S Beck-Gschaidmeier; M Schröder; Karl Walter Bock
Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue.
Biochemical pharmacology 1997;54(10):1159-62.
1996: Peter A Münzel; G Bookjans; G Mehner; T Lehmköster; Karl Walter Bock
Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6.
Archives of biochemistry and biophysics 1996;335(1):205-10.
1996: K T Kivistö; G Bookjans; Martin F Fromm; Ernst-Ulrich Griese; Peter A Münzel; Heyo K Kroemer
Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue.
British journal of clinical pharmacology 1996;42(3):387-9.
1996: G Gohl; T Lehmköster; Peter A Münzel; Dieter Schrenk; Richard Viebahn; Karl Walter Bock
TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells.
Carcinogenesis 1996;17(3):443-9.
1996: Peter A Münzel; Barbara S Bock-Hennig; S Schieback; H Gschaidmeier; S Beck-Gschaidmeier; Karl Walter Bock
Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Carcinogenesis 1996;17(2):197-202.
1994: Peter A Münzel; M Brück; Karl Walter Bock
Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase.
Biochemical pharmacology 1994;47(8):1445-8.
1994: Dieter Schrenk; Albrecht Buchmann; K Dietz; H P Lipp; H Brunner; H Sirma; Peter A Münzel; Hanspaul Hagenmaier; Rolf Gebhardt; Karl Walter Bock
Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
Carcinogenesis 1994;15(3):509-15.
1993: Karl Walter Bock; A Forster; H Gschaidmeier; M Brück; Peter A Münzel; Wolfgang Schareck; S Fournel-Gigleux; B Burchell
Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases.
Biochemical pharmacology 1993;45(9):1809-14.
1991: A B Kobusch; Dieter Schrenk; G Gans; Peter A Münzel; J Werringloer; M Ingelman-Sundberg; Karl Walter Bock
Immunochemical localization and functional characterization of cytochrome P450IIE1 in rat hepatocyte foci and nodules.
Carcinogenesis 1991;12(12):2353-6.
1991: Peter A Münzel; A Pfohl-Leszkowicz; E Röhrdanz; G Keith; G Dirheimer; Karl Walter Bock
Site-specific hypomethylation of c-myc protooncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine.
Biochemical pharmacology 1991;42(2):365-71.
1991: Dieter Schrenk; I Eisenmann-Tappe; Rolf Gebhardt; D Mayer; M el Mouelhi; E Röhrdanz; Peter A Münzel; Karl Walter Bock
Drug metabolizing enzyme activities in rat liver epithelial cell lines, hepatocytes and bile duct cells.
Biochemical pharmacology 1991;41(11):1751-7.
1991: Peter A Münzel; D Marx; H Köchel; A Schauer; Karl Walter Bock
Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas.
Journal of cancer research and clinical oncology 1991;117(6):603-7.
1990: Karl Walter Bock; Peter A Münzel; E Röhrdanz; Dieter Schrenk; L C Eriksson
Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas.
Cancer research 1990;50(12):3569-73.
1989: Peter A Münzel; Karl Walter Bock
Hypomethylation of c-myc proto-oncogene of N-nitrosomorpholine--induced rat liver nodules and of H4IIE cells.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1989;13():211-3.